172
Participants
Start Date
May 7, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
December 31, 2026
Crisugabalin
"Days 1-14: Crisugabalin 40 mg/day, 20 mg twice daily, orally. Days 15-21: Increase dose to 80 mg/day, 40 mg twice daily. If not tolerated, maintain previous dose until the end of the treatment period.~Days 22-28: Increase dose to 120 mg/day, 60 mg twice daily. If not tolerated, maintain previous dose until the end of the treatment period."
Pregabalin
"Days 1-7: Pregabalin 150 mg/day, 75 mg twice daily, orally. Days 8-14: Increase dose to 300 mg/day, 150 mg twice daily. Days 15-21: Increase dose to 450 mg/day, 225 mg twice daily. If not tolerated, maintain previous dose until the end of the treatment period.~Days 22-28: Increase dose to 600 mg/day, 300 mg twice daily. If not tolerated, maintain previous dose until the end of the treatment period."
NOT_YET_RECRUITING
Changsha Central Hospital, Changsha
NOT_YET_RECRUITING
Fujian Cancer Hospital, Fuzhou
NOT_YET_RECRUITING
Hunan Provincial People's Hospital, Changsha
NOT_YET_RECRUITING
Hunan Brain Hospital, Changsha
NOT_YET_RECRUITING
Henan Cancer Hospital (Affiliated Cancer Hospital of ZhengzhouUniversity), Zhengzhou
RECRUITING
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
NOT_YET_RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
NOT_YET_RECRUITING
Affillated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou
NOT_YET_RECRUITING
The First Affiliated Hospital of Guangxi Medical University, Nanning
NOT_YET_RECRUITING
The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou
NOT_YET_RECRUITING
Zhongshan People's Hospital, Zhongshan
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER